Chemical space exploration around indolylarylsulfone scaffold led to a novel class of highly active HIV-1 NNRTIs with spiro structural features

被引:11
作者
Gao, Shenghua [1 ]
Cheng, Yusen [1 ]
Song, Shu [1 ]
Song, Letian [1 ]
Zhao, Fabao [1 ]
Xu, Shujing [1 ]
Kang, Dongwei [1 ,2 ]
Sun, Lin [1 ]
Gao, Ping [1 ]
De Clercq, Erik [3 ]
Pannecouque, Christophe [3 ]
Liu, Xinyong [1 ,2 ]
Zhan, Peng [1 ,2 ]
机构
[1] Shandong Univ, Sch Pharmaceut Sci, Dept Med Chem, Key Lab Chem Biol,Minist Educ, Jinan 250012, Peoples R China
[2] China Belgium Collaborat Res Ctr Innovat Antivira, Jinan 250012, Peoples R China
[3] KULeuven, Rega Inst Med Res, Minderbroedersstr 10, B-3000 Leuven, Belgium
基金
中国博士后科学基金;
关键词
HIV-1; NNRTIs; Drug design; Indolylarylsulfone; Spiro ring; Fsp(3); REVERSE-TRANSCRIPTASE; COLORIMETRIC ASSAY; INHIBITORS; DISCOVERY; DESIGN; POTENT; DRUGS;
D O I
10.1016/j.ejmech.2022.114471
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
To thoroughly investigate the uncharted chemical space around the entrance channel of HIV-1 reverse transcriptase (RT) and to improve the physicochemical properties, we introduced different spiro ring structures with high Fsp(3) values as linkers at indole-2-carboxamide, attaching to various terminal substituents to enhance the interactions with the entrance channel. All the newly designed and synthesized indolylarylsulfone (IAS) derivatives exhibited moderate to excellent potency against wild-type HIV-1 with EC50 values ranging from 0.0053 to 0.19 mu M. Among them, compounds SO-7g (EC50 = 0.0053 mu M) and SO-7h (EC50 = 0.009 mu M, SI > 21552) were identified as the most two potent compounds, which displayed 30- and 16-fold improvement than nevirapine and zidovudine and comparable potency to efavirenz and etravirine. Moreover, SO-7g maintained the promising activity against a variety of mutant strains, especially for L100I (EC50 = 0.047 mu M), K103 N (EC50 = 0.056 mu M), and E138K (EC50 = 0.040 mu M). Notably, the introduction of spiro rings could effectively reduce the cytotoxicity (CC50) and greatly improve the selectivity index compared to lead compound, exemplified by SO-7h (CC50 > 214.4 mu M, SI > 21552) and SO-7a (CC50 > 233.2 mu M, SI > 20933). Additionally, the preliminary SARs based on antiviral activity and molecular simulation perspective were analyzed with a detailed description, which could point out the direction for further structural optimization.
引用
收藏
页数:10
相关论文
共 36 条
[1]   Surveillance of HIV Transmitted Drug Resistance in Latin America and the Caribbean: A Systematic Review and Meta-Analysis [J].
Avila-Rios, Santiago ;
Sued, Omar ;
Rhee, Soo-Yon ;
Shafer, Robert W. ;
Reyes-Teran, Gustavo ;
Ravasi, Giovanni .
PLOS ONE, 2016, 11 (06)
[2]   Thermodynamics of HIV-1 Reverse Transcriptase in Action Elucidates the Mechanism of Action of Non-Nucleoside Inhibitors [J].
Bec, Guillaume ;
Meyer, Benoit ;
Gerard, Marie-Mine ;
Steger, Jessica ;
Fauster, Katja ;
Wolff, Philippe ;
Burnouf, Dominique ;
Micura, Ronald ;
Dumas, Philippe ;
Ennifar, Eric .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2013, 135 (26) :9743-9752
[3]   Recent Advances in DAPYs and Related Analogues as HIV-1 NNRTIs [J].
Chen, Xuwang ;
Zhan, Peng ;
Li, Dongyue ;
De Clercq, Erik ;
Liu, Xinyong .
CURRENT MEDICINAL CHEMISTRY, 2011, 18 (03) :359-376
[4]   Approved Antiviral Drugs over the Past 50 Years [J].
De Clercq, Erik ;
Li, Guangdi .
CLINICAL MICROBIOLOGY REVIEWS, 2016, 29 (03) :695-747
[5]   Antivirals: Past, present and future [J].
De Clercq, Erik .
BIOCHEMICAL PHARMACOLOGY, 2013, 85 (06) :727-744
[6]   Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV [J].
De Clercq, Erik .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 33 (04) :307-320
[7]  
Famiglini Valeria, 2018, Antiviral Chemistry & Chemotherapy, V26, DOI 10.1177/2040206617753443
[8]  
Grant PM, 2010, CURR OPIN INVEST DR, V11, P901
[9]   Prodrug design, synthesis and pharmacokinetic evaluation of (3'R, 4'R)-3-hydroxymethyl-4-methyl-3',4'-di-O-(S)-camphanoyl-(+)-cis-khellactone [J].
Guo, Huanfang ;
Zhuang, Xiaomei ;
Qian, Keduo ;
Sun, Lianqi ;
Wang, Xiaofeng ;
Li, Hua ;
Lee, Kuohsiung ;
Xie, Lan .
ACTA PHARMACEUTICA SINICA B, 2012, 2 (02) :213-219
[10]   Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Binding Pocket: Discovery of Potent Diarylpyrimidine-Typed HIV-1 NNRTIs against Wild-Type and E138K Mutant Virus with Significantly Improved Water Solubility and Favorable Safety Profiles [J].
Huang, Boshi ;
Chen, Wenmin ;
Zhao, Tong ;
Li, Zhenyu ;
Jiang, Xiangyi ;
Ginex, Tiziana ;
Vilchez, David ;
Luque, Francisco Javier ;
Kang, Dongwei ;
Gao, Ping ;
Zhang, Jian ;
Tian, Ye ;
Daelemans, Dirk ;
De Clercq, Erik ;
Pannecouque, Christophe ;
Zhan, Peng ;
Liu, Xinyong .
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (04) :2083-2098